Page last updated: 2024-11-05

propargyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

propargyl ether: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23349
MeSH IDM0524567

Synonyms (29)

Synonym
dipropargyl ether
1-propyne, 3,3'-oxybis-
2-propynyl ether
propargyl ether
brn 1735850
propargyl ether, 98%
3-prop-2-ynoxyprop-1-yne
FT-0693254
AKOS009156420
6921-27-3
3-(prop-2-yn-1-yloxy)prop-1-yne
3-prop-2-ynyloxy-propyne
propargyl-ether
DTXSID10219242
AM85874
bispropargyl ether
3-(2-propynyloxy)-1-propyne #
dipropargyl oxide
(hc.$.cch2)2o
bis(2-propynyl) ether
di(2-propynyl) ether
mfcd00048108
propargylether
3-(prop-2-ynyloxy)prop-1-yne
P2335
propargyl ether;2-propynyl ether;di(2-propynyl)ether
BCP32374
dipropargylether
EN300-195937

Research Excerpts

Effects

ExcerptReferenceRelevance
"AG propargyl ethers with DS 2.0 have been almost exhaustively metallated with Ag2O/NH3 system to give AG-Ag acetylides derivatives with Ag/C≡C ratio equaling 0.95."( Propargylation of arabinogalactan with propargyl halides--a facile route to new functionalized biopolymers.
Grischenko, LA; Kanitskaya, LV; Larina, LI; Novikova, LN; Parshina, LN; Trofimov, BA, 2013
)
0.9
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (15.00)29.6817
2010's29 (72.50)24.3611
2020's5 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.11 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index34.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]